These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

280 related articles for article (PubMed ID: 14510246)

  • 41. Recurrent methicillin-resistant Staphylococcus aureus osteomyelitis: combination antibiotic therapy with evaluation by serum bactericidal titers.
    Aspinall SL; Friedland DM; Yu VL; Rihs JD; Muder RR
    Ann Pharmacother; 1995; 29(7-8):694-7. PubMed ID: 8520082
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Screening for Staphylococcus aureus with a reduced susceptibility to vancomycin in: a Belgian hospital].
    Piérard D; Vandenbussche H; Verschraegen I; Lauwers S
    Pathol Biol (Paris); 2004 Oct; 52(8):486-8. PubMed ID: 15465269
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Linezolid versus vancomycin for the treatment of infections caused by methicillin-resistant Staphylococcus aureus in Japan.
    Kohno S; Yamaguchi K; Aikawa N; Sumiyama Y; Odagiri S; Aoki N; Niki Y; Watanabe S; Furue M; Ito T; Croos-Dabrera R; Tack KJ
    J Antimicrob Chemother; 2007 Dec; 60(6):1361-9. PubMed ID: 17913720
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Sustained-release vancomycin sheet may help to prevent prosthetic graft methicillin-resistant Staphylococcus aureus infection.
    Hirose K; Marui A; Arai Y; Nomura T; Inoue S; Kaneda K; Kamitani T; Fujita M; Mitsuyama M; Tabata Y; Komeda M
    J Vasc Surg; 2006 Aug; 44(2):377-82. PubMed ID: 16890872
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Vascular graft infection by Staphylococcus aureus: efficacy of cefazolin, teicoplanin and vancomycin prophylaxis protocols in a rat model.
    Atahan E; Gul M; Ergun Y; Eroglu E
    Eur J Vasc Endovasc Surg; 2007 Aug; 34(2):182-7. PubMed ID: 17481929
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Treatment of methicillin-resistant Staphylococcus aureus experimental osteomyelitis with ciprofloxacin or vancomycin alone or in combination with rifampin.
    Henry NK; Rouse MS; Whitesell AL; McConnell ME; Wilson WR
    Am J Med; 1987 Apr; 82(4A):73-5. PubMed ID: 3578332
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Vancomycin therapy and the progression of methicillin-resistant Staphylococcus aureus vertebral osteomyelitis.
    Gelfand MS; Cleveland KO
    South Med J; 2004 Jun; 97(6):593-7. PubMed ID: 15255429
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Linezolid in the treatment of antibiotic-resistant gram-positive infections of the musculoskeletal system].
    Jahoda D; Nyc O; Pokorný D; Landor I; Sosna A
    Acta Chir Orthop Traumatol Cech; 2006 Oct; 73(5):329-33. PubMed ID: 17140514
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Synercid plus vancomycin for the treatment of severe methicillin-resistant Staphylococcus aureus and coagulase-negative staphylococci infections: evaluation of 5 cases.
    Sgarabotto D; Cusinato R; Narne E; Scano F; Zignol M; Gambino A; Cattelan A; Meneghetti F; Cadrobbi P
    Scand J Infect Dis; 2002; 34(2):122-6. PubMed ID: 11928842
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Empiric antibiotic therapy for acute osteoarticular infections with suspected methicillin-resistant Staphylococcus aureus or Kingella.
    Saphyakhajon P; Joshi AY; Huskins WC; Henry NK; Boyce TG
    Pediatr Infect Dis J; 2008 Aug; 27(8):765-7. PubMed ID: 18600193
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Osteomyelitis of the maxilla caused by methicillin-resistant Staphylococcus aureus.
    Cohen MA; Embil JM; Canosa T
    J Oral Maxillofac Surg; 2003 Mar; 61(3):387-90. PubMed ID: 12618981
    [No Abstract]   [Full Text] [Related]  

  • 52. First report of methicillin-resistant Staphylococcus aureus with reduced susceptibility to vancomycin in Thailand.
    Trakulsomboon S; Danchaivijitr S; Rongrungruang Y; Dhiraputra C; Susaemgrat W; Ito T; Hiramatsu K
    J Clin Microbiol; 2001 Feb; 39(2):591-5. PubMed ID: 11158112
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The importance of tissue penetration in achieving successful antimicrobial treatment of nosocomial pneumonia and complicated skin and soft-tissue infections caused by methicillin-resistant Staphylococcus aureus: vancomycin and linezolid.
    Stein GE; Wells EM
    Curr Med Res Opin; 2010 Mar; 26(3):571-88. PubMed ID: 20055750
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Comparative evaluation of tigecycline and vancomycin, with and without rifampicin, in the treatment of methicillin-resistant Staphylococcus aureus experimental osteomyelitis in a rabbit model.
    Yin LY; Lazzarini L; Li F; Stevens CM; Calhoun JH
    J Antimicrob Chemother; 2005 Jun; 55(6):995-1002. PubMed ID: 15857944
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Control of imported and acquired methicillin-resistant Staphylococcus aureus (MRSA) in mechanically ventilated patients: a dose-response study of enteral vancomycin to reduce absolute carriage and infection.
    Viviani M; van Saene HK; Dezzoni R; Silvestri L; Di Lenarda R; Berlot G; Gullo A
    Anaesth Intensive Care; 2005 Jun; 33(3):361-72. PubMed ID: 15973920
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Comparative activities of vancomycin, tigecycline and rifampin in a rat model of methicillin-resistant Staphylococcus aureus osteomyelitis.
    Vergidis P; Schmidt-Malan SM; Mandrekar JN; Steckelberg JM; Patel R
    J Infect; 2015 Jun; 70(6):609-15. PubMed ID: 25576292
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Effect of vancomycin and rifampicin on meticillin-resistant Staphylococcus aureus biofilms.
    Jones SM; Morgan M; Humphrey TJ; Lappin-Scott H
    Lancet; 2001 Jan; 357(9249):40-1. PubMed ID: 11197363
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Modified vancomycin dosing protocol for treatment of diabetic foot infections.
    Niu SC; Deng ST; Lee MH; Ho C; Chang HY; Liu FH
    Am J Health Syst Pharm; 2008 Sep; 65(18):1740-3. PubMed ID: 18769001
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Severe methicillin-resistant Staphylococcus aureus infections. Emergence of resistance to fusidic acid or fosfomycin during treatment with continuous infusion of vancomycin].
    Georges B; Brown L; Mazerolles M; Decun JF; Cougot P; Archambaud M; Suc C; Andrieu P; Virenque C
    Presse Med; 1997 Apr; 26(11):502-6. PubMed ID: 9137379
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Recent findings based on the results of the post-marketing surveillance of vancomycin hydrochloride for intravenous infusion].
    Shimada K
    Jpn J Antibiot; 2003 Aug; 56(4):259-71. PubMed ID: 14567250
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.